{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T20:10:55Z","timestamp":1774469455498,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background\/objectives<\/jats:title>\n                    <jats:p>Diabetic foot infections (DFIs) are a major cause of morbidity in low- and middle-income countries such as Pakistan, where antimicrobial resistance (AMR) and the absence of localized guidelines complicate their management. This study aimed to analyze the microbiological profile of DFIs and develop evidence-based, context-specific empirical treatment recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study at a tertiary care hospital in Pakistan, reviewing all diabetic foot related admissions between January 2022 and December 2023. Patients with clinically suspected infections had wound cultures taken and were classified by infection severity using IDSA\/IWGDF criteria. Wound specimens from 400 DFI patients were subjected to culture and CLSI-standard antimicrobial susceptibility testing. Pathogen patterns were analyzed across severity groups. A multidisciplinary stewardship team used these findings, together with international guidelines, to develop severity-specific institutional-based empiric treatment recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 118 culture-positive samples from 400 admissions were analyzed. Gram-negative organisms predominated (62%), followed by\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (25%),\n                      <jats:italic>Proteus mirabilis<\/jats:italic>\n                      (14%), and\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      (10%).\n                      <jats:italic>Methicillin-resistant Staphylococcus aureus<\/jats:italic>\n                      (\n                      <jats:italic>MRSA)<\/jats:italic>\n                      accounted for 23% and\n                      <jats:italic>methicillin-sensitive Staphylococcus aureus<\/jats:italic>\n                      (\n                      <jats:italic>MSSA)<\/jats:italic>\n                      10%.\n                      <jats:italic>E. coli<\/jats:italic>\n                      was highly susceptible to tigecycline (86%) and amikacin (83%), while\n                      <jats:italic>Proteus mirabilis<\/jats:italic>\n                      was highly susceptible to carbapenems and piperacillin\u2013tazobactam.\n                      <jats:italic>MRSA\/MSSA<\/jats:italic>\n                      remain universally susceptible to vancomycin and linezolid. Based on these patterns, severity-stratified empiric regimens were recommended. Evidence grading supported strong recommendations for moderate to severe infections (SoR: Strong; QoE: Moderate).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights the limited role of Access antibiotics in DFIs, with Watch agents serving as the main empiric therapy and Reserve drugs reserved for multidrug-resistant cases. Using hospital antibiograms, international standards, and expert consensus, we developed a locally tailored institutional guideline for DFI management, which is expected to enhance patient care and antimicrobial stewardship, with periodic updates required as resistance evolves.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1752211","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T05:22:28Z","timestamp":1770614548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrating clinical data into evidence-based practice: institutional guideline development for diabetic foot infections"],"prefix":"10.3389","volume":"17","author":[{"given":"Emmama","family":"Jamil","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University","place":["Multan, Pakistan"]},{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Hamdard University Islamabad Campus","place":["Islamabad, Pakistan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Majid","family":"Aziz","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University","place":["Multan, Pakistan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ummara","family":"Altaf","sequence":"additional","affiliation":[{"name":"Department of Environmental and Occupational Health, Tokyo University of Science","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed Mohammad","family":"Altowayan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Qassim University","place":["Buraydah, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmajeed","family":"Alqasoumi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Qassim University","place":["Buraydah, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda","family":"Arooj","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University","place":["Multan, Pakistan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaad Saeed","family":"Almutairi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Qassim University","place":["Buraydah, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zikria","family":"Saleem","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Qassim University","place":["Buraydah, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995\u20132025: prevalence, numerical estimates, and projections","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B3","unstructured":"IDF Diabetes Atlas 11th Edition.\n          \n          2025"},{"key":"B4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/ijerph20010187","article-title":"Diabetic foot complications: a retrospective cohort study","volume":"20","author":"Stancu","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0211481","DOI":"10.1371\/journal.pone.0211481","article-title":"Disparities in outcomes of patients admitted with diabetic foot infections","volume":"14","author":"Tan","year":"2019","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2174\/1381612824666180302145754","article-title":"An overview on diabetic foot infections, including issues related to associated pain, hyperglycemia and limb ischemia","volume":"24","author":"Uckay","year":"2018","journal-title":"Curr Pharm design"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1053\/j.jfas.2014.06.011","article-title":"Self-reported quality of life and diabetic foot infections","volume":"53","author":"Raspovic","year":"2014","journal-title":"J Foot Ankle Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1323315","article-title":"Current knowledge of morbidities and direct costs related to diabetic foot disorders: a literature review","volume":"14","author":"Waibel","year":"2024","journal-title":"Front Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/dme.13537","article-title":"Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study","volume":"35","author":"Ndosi","year":"2018","journal-title":"Diabetic Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/dmrr.2699","article-title":"IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes","volume":"32","author":"Lipsky","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"B11","article-title":"Bacteriological profile and antibiotic susceptibility patterns in diabetic foot infections, at lady reading hospital, Peshawar","volume":"32","author":"Ullah","year":"2020","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.4239\/wjd.v13.i12.1106","article-title":"Diabetic foot ulcers: A devastating complication of diabetes mellitus continues non-stop in spite of new medical treatment modalities","volume":"13","author":"Akkus","year":"2022","journal-title":"World J Diabetes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e3687","DOI":"10.1002\/dmrr.3687","article-title":"IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023)","volume":"40","author":"Senneville","year":"2024","journal-title":"Diabetes\/metabolism Res Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e3280","DOI":"10.1002\/dmrr.3280","article-title":"Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)","volume":"36","author":"Lipsky","year":"2020","journal-title":"Diabetes\/metabolism Res Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"tkaa017","DOI":"10.1093\/burnst\/tkaa017","article-title":"Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition)","volume":"8","author":"Wang","year":"2020","journal-title":"Burns Trauma"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1600787","article-title":"Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future","volume":"16","author":"Jamil","year":"2025","journal-title":"Front Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2872","article-title":"Pattern of infecting microorganisms and their susceptibility to antimicrobial drugs in patients with diabetic foot infections in a tertiary care hospital in Karachi, Pakistan","volume":"10","author":"Kaimkhani","year":"2018","journal-title":"Cureus"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.967733","article-title":"Prevalence of foot ulcers in diabetic patients in Punjab, Pakistan","volume":"10","author":"Akhtar","year":"2022","journal-title":"Front Public Health"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-021-00825-z","article-title":"Challenges and expectations of diabetic foot care from the patients\u2019 point of views","volume":"20","author":"Aalaa","year":"2021","journal-title":"J Diabetes Metab Disord"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2024.1393309","article-title":"A systematic review of diabetic foot infections: pathogenesis, diagnosis, and management strategies","volume":"5","author":"Maity","year":"2024","journal-title":"Front Clin Diabetes Healthcare"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01577-17","article-title":"Risk factors and outcomes for ineffective empiric treatment of sepsis caused by gram-negative pathogens: stratification by onset of infection","volume":"62","author":"Micek","year":"2018","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.14740\/jem485w","article-title":"Treatment of diabetic foot infections: a prospective study highlighting the efficacy and safety of Moxifloxacin","volume":"8","author":"Devrajani","year":"2018","journal-title":"J Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e003699","DOI":"10.1136\/bmjresp-2025-003699","article-title":"Adapting global guidelines to local contexts: optimising community-acquired pneumonia (CAP) specific prescribing in Pakistan to counter antimicrobial resistance","volume":"12","author":"Jamil","year":"2025","journal-title":"BMJ Open Respir Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"103320","DOI":"10.1016\/j.jksus.2024.103320","article-title":"Bacterial spectrum from diabetic foot Ulcers: A study of antibiotic resistance patterns and phylogenetic diversity","volume":"36","author":"Idrees","year":"2024","journal-title":"J King Saud University-Science"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30332-7","article-title":"Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data","volume":"21","author":"Klein","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30532-8","article-title":"Encouraging AWaRe-ness and discouraging inappropriate antibiotic use-the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool","volume":"19","author":"Sharland","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.08.009","article-title":"The WHO essential medicines list AWaRe book: from a list to a quality improvement system","volume":"28","author":"Sharland","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"B28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","article-title":"Classifying antibiotics in the WHO Essential Medicines List for optimal use\u2014be AWaRe","volume":"18","author":"Sharland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30532-8","article-title":"Encouraging AWaRe-ness and discouraging inappropriate antibiotic use\u2014the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool","volume":"19","author":"Sharland","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.03.014","article-title":"Exposure to World Health Organization\u2019s AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis","volume":"28","author":"Sulis","year":"2022","journal-title":"Clin Microbiol Infection"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/S1473-3099(24)00649-2","article-title":"Sustainable antimicrobial resistance surveillance: time for a global funding mechanism","volume":"25","author":"Painter","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"B32","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm Ther"},{"key":"B33","first-page":"1","article-title":"Review Article: Status and implications of the knowledge, attitudes, and practices towards AWaRe antibiotic use, resistance, and stewardship among low- and middle-income countries","author":"Saleem","year":"2025","journal-title":"JAC-Antimicrobial Resistance"},{"key":"B34","first-page":"24","article-title":"A comparable risk of extensively drug-resistant typhoid fever in the pediatric cohort during the COVID-19 pandemic","volume":"18","author":"Khan","year":"2024","journal-title":"Int J Health Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J anaesthesia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12913-018-2954-8","article-title":"Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use","volume":"18","author":"Hoffmann-E\u00dfer","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1201\/9781420014495.ch1","article-title":"An overview of the Clinical and Laboratory Standards Institute (CLSI) and its impact on antimicrobial susceptibility tests","volume":"1","author":"Barry","year":"2007","journal-title":"Antimicrobial susceptibility testing Protoc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2471\/BLT.22.288614","article-title":"The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance","volume":"101","author":"Zanichelli","year":"2023","journal-title":"Bull World Health Organ"},{"key":"B39","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/antibiotics12040687","article-title":"Distribution of causative microorganisms in diabetic foot infections: a ten-year retrospective study in a tertiary care hospital in central Malaysia","volume":"12","author":"Hadi","year":"2023","journal-title":"Antibiotics"},{"key":"B40","first-page":"10","article-title":"Microbiological pattern of diabetic foot infections at a tertiary care center in a developing country","volume":"53","author":"Miyan","year":"2017","journal-title":"Age Years"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.37185\/LnS.1.1.633","article-title":"Bacterial diversity and their antimicrobial susceptibility patterns in diabetic foot infections, a tertiary care hospital study","volume":"5","author":"Hussain","year":"2024","journal-title":"Life Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1368046","article-title":"Microbiological profile of diabetic foot infections in China and worldwide: a 20-year systematic review","volume":"15","author":"Qu","year":"2024","journal-title":"Front Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13473","article-title":"Multidrug-resistant bacteria in diabetic foot infections: experience from a portuguese tertiary centre","volume":"17","author":"Pessoa e Costa","year":"2020","journal-title":"Int Wound J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01464","article-title":"Isolation and genetic analysis of multidrug resistant bacteria from diabetic foot ulcers","volume":"6","author":"Shahi","year":"2016","journal-title":"Front Microbiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S363988","article-title":"High prevalence of multi-drug resistance and extended-spectrum beta-lactamase-producing Enterobacteriaceae among hospitalized patients presumptive for bacterial infection at Debre Berhan comprehensive specialized hospital, Ethiopia","author":"Sahle","year":"2022","journal-title":"Infection Drug Resistance"},{"key":"B46","first-page":"18","article-title":"Mutation-based fluoroquinolone resistance in carbapenem-resistant Acinetobacter baumannii and Escherichia coli isolates causing catheter-related bloodstream infections","volume":"17","author":"Tawfick","year":"2023","journal-title":"Int J Health Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-05906-1","article-title":"Antibiotic resistance in Pakistan: a systematic review of past decade","volume":"21","author":"Bilal","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3390\/microorganisms11081912","article-title":"The challenge of overcoming antibiotic resistance in carbapenem-resistant gram-negative bacteria:\u201dAttack on Titan","volume":"11","author":"Mancuso","year":"2023","journal-title":"Microorganisms"},{"key":"B49","doi-asserted-by":"publisher","first-page":"15347346231207553","DOI":"10.1177\/15347346231207553","article-title":"Parenteral vancomycin in the treatment of MRSA-associated diabetic foot infections: an unnecessary risk","author":"Joseph","year":"2023","journal-title":"Int J Lower Extremity Wounds"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e56022","DOI":"10.1371\/journal.pone.0056022","article-title":"Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections","volume":"8","author":"Chhibber","year":"2013","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1267699","article-title":"Increase in antibiotic resistance in diabetic foot infections among Peruvian patients: a single-center cross-sectional study","volume":"14","author":"Moya-Salazar","year":"2023","journal-title":"Front Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"102891","DOI":"10.1016\/j.jksus.2023.102891","article-title":"Bacterial etiology, antibiotic resistance profile and foot ulcer associated amputations in individuals with Type II diabetes mellitus","volume":"35","author":"Anita","year":"2023","journal-title":"J King Saud University-Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3947\/ic.2018.50.1.11","article-title":"Microbiology and antimicrobial therapy for diabetic foot infections","volume":"50","author":"Kwon","year":"2018","journal-title":"Infection chemotherapy"},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.18203\/2319-2003.ijbcp20214509","article-title":"Discarded old antibiotics as a new arsenal for multi-resistant isolates in diabetic foot ulcer infections: Therapeutic value of parenteral Colistin versus multi-resistant Pseudomonas speciesisolate strains","volume-title":"International Journal of Basic & Clinical Pharmacology","author":"Shabhay","year":"2021"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1752211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T05:22:30Z","timestamp":1770614550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1752211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":54,"alternative-id":["10.3389\/fendo.2026.1752211"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1752211","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"article-number":"1752211"}}